NO20026001L - 3'-promedikamenter av 2'-deoksy-<Beta>-L-nukleosider - Google Patents

3'-promedikamenter av 2'-deoksy-<Beta>-L-nukleosider

Info

Publication number
NO20026001L
NO20026001L NO20026001A NO20026001A NO20026001L NO 20026001 L NO20026001 L NO 20026001L NO 20026001 A NO20026001 A NO 20026001A NO 20026001 A NO20026001 A NO 20026001A NO 20026001 L NO20026001 L NO 20026001L
Authority
NO
Norway
Prior art keywords
nucleosides
deoxy
promoters
beta
compositions
Prior art date
Application number
NO20026001A
Other languages
English (en)
Other versions
NO20026001D0 (no
Inventor
Martin L Bryant
Gilles Gosselin
Jean Louis Imbach
Original Assignee
Univ Montpellier Ii
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Montpellier Ii filed Critical Univ Montpellier Ii
Publication of NO20026001D0 publication Critical patent/NO20026001D0/no
Publication of NO20026001L publication Critical patent/NO20026001L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Foreliggende oppfinnelse angår forbindelser, preparater og metoder for behandling av en vert infisert med et heptatitt B-virus. Spesielt beskrives forbindelser og preparater av 3" -estere av 2'-deciksy-P-L-nukleosider som kan administreres enten alene eller i kombinasjoner med andre anti-hepatitt B-midler. Forbindelsene og preparatene av 3\ 5'-estere av 2'-deoksy-P-L-nukleosider beskrives som kan administreres enten alene eller med andre anti-hepatitt B-midler.
NO20026001A 2000-06-15 2002-12-13 3'-promedikamenter av 2'-deoksy-<Beta>-L-nukleosider NO20026001L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21210000P 2000-06-15 2000-06-15
PCT/US2001/019147 WO2001096353A2 (en) 2000-06-15 2001-06-15 3'-PRODRUGS OF 2'-DEOXY-β-L-NUCLEOSIDES

Publications (2)

Publication Number Publication Date
NO20026001D0 NO20026001D0 (no) 2002-12-13
NO20026001L true NO20026001L (no) 2003-02-12

Family

ID=22789563

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20026001A NO20026001L (no) 2000-06-15 2002-12-13 3'-promedikamenter av 2'-deoksy-<Beta>-L-nukleosider

Country Status (27)

Country Link
EP (1) EP1296995B1 (no)
JP (1) JP4639032B2 (no)
KR (2) KR20030032967A (no)
CN (3) CN101012259A (no)
AP (1) AP1771A (no)
AR (1) AR035711A1 (no)
AT (1) ATE411332T1 (no)
AU (2) AU2001266927B2 (no)
BR (1) BR0111732A (no)
CA (1) CA2413163C (no)
CZ (1) CZ2003122A3 (no)
DE (1) DE60136181D1 (no)
EA (1) EA005774B1 (no)
ES (1) ES2317912T3 (no)
IL (3) IL153379A0 (no)
MA (1) MA27126A1 (no)
MX (1) MXPA02012443A (no)
MY (1) MY141594A (no)
NO (1) NO20026001L (no)
NZ (2) NZ535246A (no)
OA (1) OA12384A (no)
PE (1) PE20020216A1 (no)
PL (1) PL360404A1 (no)
UY (1) UY26779A1 (no)
WO (1) WO2001096353A2 (no)
YU (1) YU94802A (no)
ZA (2) ZA200300168B (no)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100457118C (zh) 2000-04-13 2009-02-04 法玛塞特有限公司 用于治疗肝炎病毒感染的3′-或2′-羟甲基取代的核苷衍生物
MY164523A (en) 2000-05-23 2017-12-29 Univ Degli Studi Cagliari Methods and compositions for treating hepatitis c virus
NZ547204A (en) 2000-05-26 2008-01-31 Idenix Cayman Ltd Methods and compositions for treating flaviviruses and pestiviruses
US6787526B1 (en) 2000-05-26 2004-09-07 Idenix Pharmaceuticals, Inc. Methods of treating hepatitis delta virus infection with β-L-2′-deoxy-nucleosides
EP1536804A4 (en) 2002-06-28 2007-10-31 Idenix Cayman Ltd 2'-C-METHYL-3'-O-L-VALINESTER-RIBOFURANOSYLCYTIDINE FOR THE TREATMENT OF FLAVIVIRIDAE INFECTIONS
WO2004003000A2 (en) 2002-06-28 2004-01-08 Idenix (Cayman) Limited 1’-, 2'- and 3'- modified nucleoside derivatives for treating flaviviridae infections
EP2799442A1 (en) * 2002-06-28 2014-11-05 IDENIX Pharmaceuticals, Inc. Modified 2' and 3' -nucleoside prodrugs for treating flaviridae infections
US7608600B2 (en) 2002-06-28 2009-10-27 Idenix Pharmaceuticals, Inc. Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
ES2547002T3 (es) 2002-09-13 2015-09-30 Novartis Ag Beta-L-2' desoxinucleósidos para el tratamiento de cepas de VHB resistentes
HUE033832T2 (en) 2002-11-15 2018-01-29 Idenix Pharmaceuticals Llc 2'-methyl nucleosides in combination with interferon and Flaviviridae mutation
CN101415719A (zh) 2003-03-20 2009-04-22 微生物化学及药品有限公司 生产2’-脱氧-β-L-核苷的方法
WO2004096149A2 (en) * 2003-04-28 2004-11-11 Idenix (Cayman) Limited Industrially scalable nucleoside synthesis
ES2586668T3 (es) 2003-05-30 2016-10-18 Gilead Pharmasset Llc Análogos de nucleósidos fluorados modificados
WO2005003374A2 (en) 2003-06-30 2005-01-13 Idenix (Cayman) Limited SYNTHESIS OF β-L-2-DEOXY NUCLEOSIDES
WO2005107742A1 (en) 2004-05-05 2005-11-17 Yale University Novel antiviral helioxanthin analogs
MX2007003085A (es) 2004-09-14 2007-08-02 Pharmasset Inc Preparacion de 2'-fluoro-2'-alquilo sustituido u otras ribofuranosil pirimidinas y purinas opcionalmente sustituidas y sus derivados.
US7524831B2 (en) 2005-03-02 2009-04-28 Schering Corporation Treatments for Flaviviridae virus infection
CN101242842A (zh) 2005-06-17 2008-08-13 诺瓦提斯公司 Sanglifehrin在hcv中的用途
GB0609178D0 (en) 2006-05-09 2006-06-21 Univ Cardiff Novel compounds
US7897737B2 (en) 2006-12-05 2011-03-01 Lasergen, Inc. 3′-OH unblocked, nucleotides and nucleosides, base modified with photocleavable, terminating groups and methods for their use in DNA sequencing
US7964580B2 (en) 2007-03-30 2011-06-21 Pharmasset, Inc. Nucleoside phosphoramidate prodrugs
TW200946541A (en) 2008-03-27 2009-11-16 Idenix Pharmaceuticals Inc Solid forms of an anti-HIV phosphoindole compound
NZ590265A (en) 2008-06-11 2012-11-30 Lasergen Inc Nucleotides and nucleosides and methods for their use in dna sequencing
MX2011006891A (es) 2008-12-23 2011-10-06 Pharmasset Inc Fosforamidatos de nucleosidos.
NZ593647A (en) 2008-12-23 2013-08-30 Gilead Pharmasset Llc Synthesis of purine nucleosides
EP2376514A2 (en) 2008-12-23 2011-10-19 Pharmasset, Inc. Nucleoside analogs
US8618076B2 (en) 2009-05-20 2013-12-31 Gilead Pharmasset Llc Nucleoside phosphoramidates
TWI576352B (zh) 2009-05-20 2017-04-01 基利法瑪席特有限責任公司 核苷磷醯胺
AU2011235112B2 (en) 2010-03-31 2015-07-09 Gilead Pharmasset Llc Nucleoside phosphoramidates
MX2012011222A (es) 2010-04-01 2013-01-18 Centre Nat Rech Scient Compuestos y composiciones farmaceuticas para el tratamiento de infecciones virales.
AU2011336632B2 (en) 2010-11-30 2015-09-03 Gilead Pharmasset Llc Compounds
US9243025B2 (en) 2011-03-31 2016-01-26 Idenix Pharmaceuticals, Llc Compounds and pharmaceutical compositions for the treatment of viral infections
WO2013039855A1 (en) 2011-09-12 2013-03-21 Idenix Pharmaceuticals, Inc. Compounds and pharmaceutical compositions for the treatment of viral infections
CN104024269B (zh) 2011-09-13 2017-05-24 激光基因公司 5‑甲氧基，3’‑oh未阻断，可快速光切割的终止核苷酸以及用于核酸测序的方法
NZ623396A (en) 2011-09-16 2016-07-29 Gilead Pharmasset Llc Methods for treating hcv
US8889159B2 (en) 2011-11-29 2014-11-18 Gilead Pharmasset Llc Compositions and methods for treating hepatitis C virus
AR090699A1 (es) * 2012-04-18 2014-12-03 Biocryst Pharm Inc Compuestos inhibidores de la actividad de la arn polimerasa viral
LT2950786T (lt) 2013-01-31 2020-03-10 Gilead Pharmasset Llc Dviejų antivirusinių junginių preparatų kompozicija
NZ716840A (en) 2013-08-27 2017-06-30 Gilead Pharmasset Llc Combination formulation of two antiviral compounds
WO2019200340A1 (en) * 2018-04-12 2019-10-17 Modis Therapeutics Inc. Prodrugs of deoxynucleosides for treatment of diseases cased by unbalanced nucleotide pools

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4958013A (en) * 1989-06-06 1990-09-18 Northwestern University Cholesteryl modified oligonucleotides
IT1246983B (it) * 1990-11-13 1994-12-12 Consiglio Nazionale Ricerche L-2'-desossiuridine e composizioni farmaceutiche che le contengono.
US5559101A (en) * 1994-10-24 1996-09-24 Genencor International, Inc. L-ribofuranosyl nucleosides
SE9603178L (sv) * 1996-08-30 1997-09-22 Scania Cv Ab Anordning vid ett fordon för monterbar anfästning av en förarplatsmodul
ES2579903T3 (es) * 1998-08-10 2016-08-17 Centre National De La Recherche Scientifique (Cnrs) Beta-L-2'-desoxi-nucleósidos para el tratamiento de la hepatitis B

Also Published As

Publication number Publication date
EP1296995A2 (en) 2003-04-02
NZ535246A (en) 2006-06-30
AP1771A (en) 2007-08-23
JP2004533403A (ja) 2004-11-04
CN1452627A (zh) 2003-10-29
NO20026001D0 (no) 2002-12-13
BR0111732A (pt) 2003-06-24
UY26779A1 (es) 2001-12-28
ZA200404306B (en) 2005-06-15
CN1900104A (zh) 2007-01-24
AR035711A1 (es) 2004-07-07
ATE411332T1 (de) 2008-10-15
DE60136181D1 (de) 2008-11-27
IL178864A0 (en) 2007-03-08
PE20020216A1 (es) 2002-04-16
CZ2003122A3 (cs) 2003-06-18
WO2001096353A3 (en) 2002-04-18
CA2413163A1 (en) 2001-12-20
ZA200300168B (en) 2004-07-07
MA27126A1 (fr) 2005-01-03
AU2001266927B2 (en) 2006-12-14
KR20070048277A (ko) 2007-05-08
PL360404A1 (en) 2004-09-06
IL153379A0 (en) 2003-07-06
AU6692701A (en) 2001-12-24
ES2317912T3 (es) 2009-05-01
MY141594A (en) 2010-05-14
OA12384A (en) 2006-04-17
JP4639032B2 (ja) 2011-02-23
KR20030032967A (ko) 2003-04-26
EP1296995B1 (en) 2008-10-15
NZ523632A (en) 2005-03-24
AP2003002713A0 (en) 2003-03-31
CA2413163C (en) 2008-11-18
MXPA02012443A (es) 2004-09-10
CN1295242C (zh) 2007-01-17
WO2001096353A2 (en) 2001-12-20
IL153379A (en) 2007-02-11
CN101012259A (zh) 2007-08-08
EA005774B1 (ru) 2005-06-30
EA200300023A1 (ru) 2003-08-28
YU94802A (sh) 2006-03-03

Similar Documents

Publication Publication Date Title
NO20026001L (no) 3&#39;-promedikamenter av 2&#39;-deoksy-&lt;Beta&gt;-L-nukleosider
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
UY26724A1 (es) Métodos y composiciones para tratar el virus de la hepatitis c
BR9913406A (pt) Processo de tratamento de infecção causada por pelo menos um vìrus da famìlia flaviviridae e de doença associada com a citada infecção em um hospedeiro vivo possuindo a citada infecção
PL330407A1 (en) Substituted cyclopentane compounds useful as neuraminidaze inhibitors
BR0312271A (pt) compostos, composições e seus usos para o tratamento de infecções por flaviviridae
BR0009267A (pt) Tratamento da hepatite c com o uso da hipertermia
BR9913935A (pt) Métodos de tratamento e prevenção de infecção causada por pelo menos um vìrus da famìlia dos flaviviridae e doença associada com a dita infecção em um hospedeiro vivo
WO2004011478A3 (en) Anti-viral 7-deaza d-nucleosides and uses thereof
BR0013771A (pt) Composto, métodos de tratamento de uma infecção viral em um mamìfero, de inibir a transcriptase reversa do hiv, e de prevenção da infecção do hiv ou de tratar a infecção do hiv, uso de um composto, e, composição farmacêutica
NO20092585L (no) Forbindelser og farmasoytiske sammensetninger for behandling av virale infeksjoner
WO2003055896A3 (en) Anti-viral 7-deaza l-nucleosides
WO2006101538A3 (en) Andrographolide derivatives to treat viral infections
EA200000836A1 (ru) Применение n-замещенных 1,5-дидезокси-1,5-имино-d-глюцитных производных для лечения инфекций, вызываемых вирусами гепатита
DE60036862D1 (de) Synergistische hemmung von viralreplikation durch langkettigen kohlenwasserstoffe und nucleosid-analoge
BR9911619B1 (pt) VAClNA VIVA DE PESTlVÍRUS ATENUADA, SEU USO, COMPOSIÇÃO FARMACÊUTICA, BEM COMO PROCESSO PARA ATENUAR PESTIVÍRUS
BR0311223A (pt) Método para o uso de derivados de piranindol para tratar infecção pelo vìrus da hepatite c
BR9916043A (pt) Composto, uso do mesmo e de seus saisfarmaceuticamente aceitáveis, e, composiçãofarmacêutica para tratamento de infecções deherpes viral em pacientes
NO965591L (no) Kombinasjonsbehandling av HIV-infeksjon
WO2006085141A8 (en) Compositions and methods for treating or preventing hepadnaviridae infection
RS53223B (en) METHODS AND MIXTURES FOR TREATMENT OF VIRAL HEPATITIS C
KR900005991A (ko) 옥트레오티드(Octreotide)를 함유한 약학적 조성물
UA37622A (uk) 1,5-піперидил - 3,7-біс/діетаноламіну/ - піримідил ізовалеріанат, що використовується для діагностики вірусних інфекцій